Burkhard Jansen
Chief Tech/Sci/R&D Officer bei DERMTECH, INC.
Profil
Burkhard Jansen was the founder of Novelix Pharmaceuticals, Inc. (founded in 2005) where he held the title of President & Chief Executive Officer.
He is currently working as the Chief Medical Affairs Officer at DermTech, Inc. since 2019.
In his former positions, Dr. Jansen served as the Chief Medical Officer at DermTech Operations, Inc. from 2013 to 2019 and as the President-Clinical Development at OncoGenex Pharmaceuticals, Inc. Dr. Jansen also worked as a Principal at the University of Vienna.
He obtained his doctorate degree from the University of Graz.
Aktive Positionen von Burkhard Jansen
| Unternehmen | Position | Beginn |
|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 03.09.2019 |
Ehemalige bekannte Positionen von Burkhard Jansen
| Unternehmen | Position | Ende |
|---|---|---|
DermTech Operations, Inc.
 DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 01.08.2019 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Chief Tech/Sci/R&D Officer | - |
| University of Vienna | Corporate Officer/Principal | - |
Novelix Pharmaceuticals, Inc.
 Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Chief Executive Officer | - |
Ausbildung von Burkhard Jansen
| University of Graz | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DERMTECH, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novelix Pharmaceuticals, Inc.
Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Health Services |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Health Technology |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
